If you have been reading about actin-binding motif and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-11-04. Numbers and descriptions here follow the published literature rather than marketing material.
Thymosin beta-4 was isolated from calf thymus in the early 1980s and later characterised as an abundant intracellular actin-sequestering protein. Interest in short synthetic fragments grew once the actin-binding motif had been mapped to the middle of the sequence. TB-500 came out of that line of work as a truncated analogue rather than a natural isolate, and it is now sold mainly to laboratories. Published studies on the fragment have been largely in vitro or in animal models, and controlled human trials remain sparse, so claims about effects in people rest on extrapolation.
Literature and online discussion often conflate TB-500 with full-length thymosin beta-4, even though the two differ in size and are not interchangeable in analytical terms. The fragment is produced by solid-phase peptide synthesis, and the product is a defined seven-residue chain rather than a biological extract. Because the term is a trade-style label, two vendors may supply materials of the same nominal sequence but different counter-ion content, purity, or water content. Comparisons across studies are therefore difficult unless the exact sequence and purity are reported.
Detection in biological matrices generally relies on liquid chromatography coupled with tandem mass spectrometry, because the peptide lacks a convenient ultraviolet chromophore beyond the amide backbone. Immunoassays have been described, but antibodies raised against the fragment can cross-react with the full-length protein or with unrelated peptides, so findings usually require confirmation by a second technique. Sample preparation typically involves protein precipitation followed by solid-phase extraction. Reported detection windows depend on dose, route, matrix, and instrument sensitivity.
Lyophilised material is stable for extended periods when kept dry and cold, and suppliers typically recommend storage well below freezing. Once dissolved, the peptide is handled at refrigeration temperatures and used within a short period, because peptide bonds and the acetylated terminus can be affected by repeated freeze-thaw cycles, proteases, or extreme pH. Bacteriostatic water and saline are both described as solvents, although preservatives can interfere with some analytical workflows. Reconstituted solutions are inspected for particulates before use.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Supplied as a lyophilised cake in sealed vials |
| Solubility class | Freely soluble in water | Polar and charged side chains dominate the sequence |
| Typical storage temperature | -20 °C or below | Dry and dark; a desiccant is often recommended |
| Identity confirmation | Mass spectrometry | Observed mass compared with the theoretical value |
| Common synonyms | Thymosin beta-4 fragment | Also written as T beta 4 fragment 17-23 |
TB-500 is a synthetic peptide whose sequence corresponds to a short fragment near the N-terminus of thymosin beta-4, a small protein present in most mammalian cells. The fragment is commonly cited as containing the actin-binding region of the parent molecule, which is why it appears in laboratory work on cell migration and tissue repair. Suppliers distribute it as a lyophilised powder intended for research use. Its identity is defined by amino acid sequence and by the presence of an acetyl group on the N-terminal residue.
Full-length thymosin beta-4 consists of roughly forty-three amino acids and ranks among the more abundant small proteins in the cytoplasm. The fragment is much shorter, so it cannot reproduce every function attributed to the intact molecule. In cell culture, short actin-binding motifs can interfere with filament dynamics and cell movement, but such observations come from controlled experiments rather than from whole-animal work. Whether a truncated fragment produces the same effects as the parent protein remains an open question.
Interest in the peptide grew during the 2000s and 2010s, when studies of tendon and ligament injuries in horses reported changes in lesion size after treatment. Those reports circulated widely outside the scientific literature and shaped much of the current online discussion. Subsequent reviews noted inconsistent study design, small groups, and a shortage of independent replication. Popular descriptions often blur the line between the fragment, the complete protein, and unrelated growth factors, which complicates comparisons across sources.
Once in solution, short peptides are generally less stable than the dry powder, and repeated freeze-thaw cycles are a common cause of loss. Laboratory guidance usually calls for aliquoting on first dissolution and storing aliquots at -20 °C or below, away from light. Adsorption to plastic and glass surfaces can lower measured concentration, particularly at low concentrations, so container material and buffer choice can affect results. Visible cloudiness, colour change or unexpected precipitate is a signal to re-check the material.
Purity is normally assessed by reversed-phase HPLC, with the main peak reported as a percentage of total peak area, while identity is confirmed by mass spectrometry. Electrospray and MALDI-TOF instruments are both used, and the observed mass is compared with the value calculated from the stated sequence. Ion-exchange or size-exclusion methods appear where aggregation or charge variants are of interest. Water content, counter-ion content and residual trifluoroacetate from purification are separate variables that can shift the measured mass and should be weighed when reading a certificate of analysis.
TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.
Thymosin beta-4 contains 43 amino acids and has a reported molecular mass near 4963 Da. The short fragment most often associated with the TB-500 label, an acetylated chain beginning LKKTETQ, has a reported mass near 889 Da, so the two are easily separated in analytical work. Mass spectrometry and amino acid analysis can confirm which material is present in a given sample. Statements treating TB-500 and thymosin beta-4 as interchangeable are therefore imprecise, even though the two appear together in much of the same literature.
Interest in the compound comes largely from studies of the parent protein, which participates in actin sequestration, cell migration and tissue repair processes. Whether a short fragment reproduces those activities is a separate question that remains open in the published record. Many summaries describe mechanisms by analogy to thymosin beta-4 rather than from direct measurements on the fragment. Claims about activity should be treated as provisional unless a cited study specifies the exact peptide, its purity and the assay used.
This led to communal strife in Singapore, culminating in the 1964 race riots. On 7 August 1965, after series of secret negotiations between the Malaysian and Singaporean leaders, a separation agreement was signed, paving way for a sudden but planned independence for Singapore. On 9 August 1965, the Malaysian Parliament voted 126 to 0 to pass a constitutional amendment bill, thereby separating Singapore from Malaysia, which left Singapore as a newly independent country.
The mucosa is the innermost layer of the gastrointestinal tract. The mucosa surrounds the lumen, or open space within the tube. This layer comes in direct contact with digested food (chyme). The mucosa is made up of:
== See also == Hydrogenosomes and mitosomes – mitochondrion-related organelles (MROs) Spinoloricus cinziae – an anaerobic microbial animal with hydrogenosome-like organelles Monocercomonoides – genus of eukaryotes that lack mitochondria and MROs entirely Anaerobic digestion Microbial fuel cell Standard electrode potential (data page) Table of standard reduction potentials for half-reactions important in biochemistry Lithotrophs
Sources: en.wikipedia.org
=== Research conducted === In 1963, Nikolai Kardashev and Gennady Borissovich Sholomitskii studied the CTA 102 radio source on the 920 MHz band from the Crimea Deep Space Station, looking for signs of a Type III civilization. CTA 102 had been discovered by Sholomitskii a year earlier, and Kardashev quickly saw it as a possible artificial source to study in order to validate his classification. The observation lasted until February 1965, and on April 12, Sholomitskii announced to the press (via the Russian ITAR-TASS) that Soviet astronomers had discovered a signal that could be of extraterrestrial origin. On April 14, he gave a conference in Moscow where he repeated his announcement; but by November 1964, two American astronomers had identified CTA 102 as a quasar, and their publication definitively closed the "CTA 102 case". It was the study of this source that had led to the Byurakan conference in 1964. In 1975 and 1976, the American astronomers Frank Drake and Carl Sagan searched at Arecibo for signs of Type II civilizations in four galaxies of the Local Group: M33, M49, Leo I and Leo II. The year before, the two men had sent mankind's first message to M13. The results were published as "The Search for Extraterrestrial Intelligence" in Scientific American in May 1975. In 1976, Kardashev, Troitskii, and Gindilis used the RATAN-600 radio telescope in the North Caucasus to search for signals from Type II or III civilizations in the Milky Way and other nearby galaxies.
== Education == Nuzzo graduated from the University of South Florida with a bachelor's degree in industrial engineering and went on to obtain her Ph.D in statistics from Stanford University in 2004, supervised by Richard A. Olshen. Her dissertation was written on the usage of stochastic models in biochemistry. Nuzzo also graduated from the University of California Santa Cruz's science writing program.
In 2008, she portrayed an embattled guidance counselor in the gay-themed mystery film On the Other Hand, Death, and a supporting role as Laurie Strode's therapist, in Rob Zombie's Halloween II (2009). In an interview with the LGBT publication The Advocate, Kidder discussed her later career choices: "I'm not choosy at all! I'll do practically anything. I'm the biggest whore on the block. I live in a little town in Montana, and you have to drag me out of here to get to LA, so I'm not readily available. But unless it's something sexist or cruel, I just love to work. I've done all sorts of things, but you just haven't seen them because they're often very bad and shown at four in the morning." In 2015, Kidder won an Emmy Award for Outstanding Performer in Children's Programming for her performance in R.L. Stine's The Haunting Hour. She will appear posthumously in the psychological thriller Robber's Roost, directed by Galen Rosenthal, which will be her final film role.
Sources: en.wikipedia.org
No. Thymosin beta-4 is a 43-residue protein, while TB-500 matches only residues 17 to 23 of that chain. The two are related but differ in size, and a method that identifies one does not automatically identify the other.
It corresponds to the actin-binding region of thymosin beta-4. Commercial synthesis reproduces that seven-residue stretch, usually with an acetyl group on the N-terminus.
It is not authorised as a medicine in the United States or the European Union and is distributed as a research chemical. Labels consequently carry research-use-only statements rather than clinical indications.
The most common approach is liquid chromatography with tandem mass spectrometry after extraction from blood or urine. Immunoassays exist but are generally treated as screening tools because of cross-reactivity.